¼Óº¸
VIP
ÅëÇÕ°Ë»ö

Çѱ¹¾àÁ¦ÇÐȸ, 2023 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾ö ¼º·á

¸Ó´ÏÅõµ¥ÀÌ
  • À̵¿¿À ±âÀÚ
  • Ä«Ä«¿ÀÅå °øÀ¯Çϱâ
  • Ä«Ä«¿ÀÅå ³ª¿¡°Ô Àü¼ÛÇϱâ
  • ÆäÀ̽ººÏ
  • Æ®À§ÅÍ
  • ³×À̹ö
  • ÅÚ·¹±×·¥
  • ¹®ÀÚ
  • 2023.04.18 16:55
  • ±ÛÀÚÅ©±âÁ¶Àý
»ç´Ü¹ýÀÎ Çѱ¹¾àÁ¦ÇÐȸ(ȸÀå ¿ø±Ç¿¬)´Â Áö³­ 14ÀÏ ¿ÀÀü 9½Ã30ºÐºÎÅÍ ¿ÀÈÄ 5½Ã45ºÐ±îÁö ¼­¿ï ´õÄÉÀÌÈ£ÅÚ¿¡¼­ '2023 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾ö'À» °³ÃÖ, ¼ºÈ²¸®¿¡ ¸¶ÃÆ´Ù°í 18ÀÏ ¹àÇû´Ù.

2023 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾ö/»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
2023 °úÇÐÀÇ ´Þ ±â³ä ½ÉÆ÷Áö¾ö/»çÁøÁ¦°ø=Çѱ¹¾àÁ¦ÇÐȸ
Çѱ¹¾àÁ¦ÇÐȸ¿Í Controlled Release Society Korea Chapter°¡ °øµ¿ ÁÖÃÖÇÑ À̹ø ½ÉÆ÷Áö¾öÀº °ü·Ã ºÐ¾ß ¿¬±¸ÀÚ 260¿© ¸íÀÌ Âü¼®ÇØ Â÷¼¼´ë ¾à¹° Àü´Þ±â¼úÀÇ ¹æÇ⼺¿¡ ´ëÇØ Åä·ÐÇß´Ù.


½ÉÆ÷Áö¾öÀº ¿ø±Ç¿¬ Çѱ¹¾àÁ¦ÇÐȸÀåÀÇ °³È¸»ç¿Í ¿ÀÀ¯°æ ½ÄÇ°ÀǾàÇ°¾ÈÀüóÀåÀÇ Ãà»ç·Î ½ÃÀÛµÆÀ¸¸ç, 'Bio-Pharmaceutical technology for the development of next-generation therapeutics'¸¦ ÁÖÁ¦·Î 3°³ÀÇ ¼¼¼Ç¿¡¼­ ¿ì¼öÇÑ ¿¬±¸¸¦ ¼öÇàÇÏ°í ÀÖ´Â »êÇп¬ ÁßÁø ¹× ½ÅÁø ¿¬±¸ÀÚ 9ÀÎÀÇ °­¿¬À» À̾´Ù. Biomaterial-based immunotherapy, AI-based drug discovery platform, ¸¶ÀÌÅ©·Î/³ª³ë ½Ã½ºÅÛÀ» ÀÌ¿ëÇÑ À¯ÀüÀÚ Ç¥Àû °ËÃâ ¹× CRISPR/Cas9 À¯ÀüÀÚ ÆíÁý µîÀÇ À¶ÇÕÀû ¾àÁ¦ÇÐ ¿¬±¸ ±â¹ýµéÀ» ¼Ò°³ÇÏ°í »õ·Î¿î ¾à¹°Àü´Þ ±â¼úÀÇ ¹æÇ⼺À» Á¦½ÃÇß´Ù.

À̹ø ½ÉÆ÷Áö¾ö¿¡ ÃʺùµÈ ¿¬ÀÚ 9ÀÎÀÇ ÁÖÁ¦ ¹ßÇ¥´Â ´ÙÀ½°ú °°´Ù.

ù ¹ø° ¼¼¼Ç: ¡âBiomaterial-based immunotherapy (±èº´¼ö ±³¼ö, ¼­¿ï´ë È­Çлý¹°°øÇкÎ) ¡âHuman intestinal organoid and its applications (¼Õ¹Ì¿µ ¼¾ÅÍÀå, Çѱ¹»ý¸í°øÇבּ¸¿ø) ¡âNanoparticle-based nitric oxide modulation for the treatment of various disease (±è¿øÁ¾ ±³¼ö, Æ÷Ç×°ø°ú´ë È­Çаú)


µÎ ¹ø° ¼¼¼Ç: ¡âFrom AI-driven design to preclinical investigation for therapeutic potential: polymer-based micelle delivery system for poorly soluble drugs (ȲµÎÇü ±³¼ö, ´Ü±¹´ë Á¦¾à°øÇаú) ¡âGenetic target detection and CRISPR/Cas9 gene editing using micro/nano systems (°­À¯°æ ±³¼ö, °æ»ó±¹¸³´ë ¾àÇдëÇÐ) ¡âTargeting and modulating the inflammatory DAMP molecules for successful cell therapy (À̵¿À± ±³¼ö, ÇѾç´ë »ý¸í°øÇаú)

¼¼ ¹ø° ¼¼¼Ç: ¡âBiomimetic hydrogels with high mechanical properties and adhesiveness (±èÀçÀ± ±³¼ö, ¼º±Õ°ü´ë È­ÇаøÇÐ/°íºÐÀÚ°øÇкÎ) ¡âArtificial Intelligence (AI)-based drug discovery platform and drug development (±è¼öÇö Àü·«ÆÀÀå, µð¾îÁ¨¢ß) ¡âCarbohydrate, protein, and lipid: The Three Musketeers of cancer drug delivery nanoparticles (ÀÌÀ翵 ±³¼ö, Ãæ³²´ë ¾àÇдëÇÐ)

¿ø±Ç¿¬ ȸÀåÀº "ICT(Á¤º¸Åë½Å±â¼ú) À¶ÇÕÀÌ ½Å¾à ¿¬±¸°³¹ß ºÐ¾ß¿¡ Å« ±âȸ¸¦ Á¦°øÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ½Å¾à °³¹ß¿¡ ´ëÇÑ ±â´ë°¡ ³ô¾ÆÁö°í ÀÖ´Ù. Çѱ¹¾àÁ¦ÇÐȸ´Â ÀÌ·¯ÇÑ È¯°æ º¯È­¿¡ ´ëÀÀÇÏ¿© Á¦¾à¡¤¹ÙÀÌ¿À °ü·Ã Çаè¿Í »ê¾÷°è¿¡ ÃֽŠ¿¬±¸µ¿Çâ ¹× ±â¼úÁ¤º¸¸¦ Á¦°øÇϱâ À§ÇØ ´õ¿í ³ë·ÂÇÏ°Ú´Ù"¸ç "À̹ø ÇÐȸ´Â ´Ù¾çÇÑ ½Å¾à ¿¬±¸°³¹ß¿¡ °ü·ÃµÈ ÃÖ½ÅÀÇ ¾àÁ¦ÇÐÀû ½Å±â¼ú°ú ¿ø¸®¸¦ °øÀ¯ÇÏ°í Åä·ÐÇÏ¿© ¹Ì·¡ÁöÇâÀûÀÎ ½Å¾à °³¹ß Àü·«ÀÇ Åä´ë¸¦ ±¸ÃàÇÏ´Â ÀåÀÌ µÉ °Í"À̶ó°í °­Á¶Çß´Ù.



¸Ó´ÏÅõµ¥ÀÌ ÁÖ¿ä´º½º

HBM ²ø°í D·¥¡¤³½µå ¹Ð°í¡¦¹ÝµµÃ¼ ½´ÆÛ»çÀÌŬ
³×À̹ö ¸ÞÀο¡¼­ ¸Ó´ÏÅõµ¥ÀÌ ±¸µ¶ ´ÙÀ½ ¾ð·Ð»ç Ȩ¿¡¼­ ¸Ó´ÏÅõµ¥ÀÌ ±¸µ¶

º£½ºÆ®Å¬¸¯

¿À´ÃÀÇ ²ÜÆÁ

  • ´º½º ¼Ó ¿À´Ã
  • ´õ¿µ»ó
  • ³¯¾¾´Â?
  • ÇコÅõµ¥ÀÌ

¸¹ÀÌ º» ´º½º

À¯´ÏÄÜÆÑÅ丮 ±Û·Î¹úÁøÃâ ÆнºÆ®Æ®·¢
Ç®¹ÎÁö

Æ÷Åä / ¿µ»ó